MétaCan
Menu
Back to cohort
Record W2998202824

Intravenous Ketamine for Adults with Treatment-Resistant Depression or Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines

2019· review· en· W2998202824 on OpenAlexaboutno aff
Kexin Li, Hannah Loshak

Bibliographic record

VenueEurope PMC (PubMed Central) · 2019
Typereview
Languageen
FieldMedicine
TopicTreatment of Major Depression
Canadian institutionsnot available
Fundersnot available
KeywordsElectroconvulsive therapyAntidepressantAnxietyPsychiatryMajor depressive disorderDepression (economics)Treatment-resistant depressionPsychologyMedicineSchizophrenia (object-oriented programming)Mood
DOInot available

Abstract

fetched live from OpenAlex

Treatment-resistant depression (TRD) is a condition that affects patients with depression who have not achieved an adequate response to conventional antidepressant therapies. TRD is commonly defined as major depressive disorder (MDD) with at least two prior treatment failures given adequate dose and duration. For patients with bipolar disorder, TRD is defined as a minimum of one prior treatment failure. Compared to non-treatment resistant MDD, TRD is associated with reduced quality of life, social and occupational impairment, comorbidities, and higher likelihood of prior suicide attempts. Patients with TRD are twice as likely to be hospitalized than patients with non-treatment resistant MDD; and increased hospitalization is associated with substantially increased resource utilization., Risk factors for TRD include old age, divorced or widowed marital status, and concomitant psychiatric disorders such as anxiety and personality disorders.Post-traumatic stress disorder (PTSD) occurs as a response to a traumatic event or extreme stressor (such as military combat, sexual assault, torture, being kidnapped, severe car accidents, and natural disasters). Patients experience symptoms that may include emotional impairment due to depression, anxiety, flashbacks, insomnia, feelings of guilt of having survived, and difficulty concentrating. In 2008, the Canadian lifetime prevalence rate of PTSD was estimated to be 9.2%.Antidepressants including selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are commonly prescribed agents for depression, while electroconvulsive therapy (ECT) is the gold standard and a late-line therapy for TRD.,Ketamine is a N-methyl-d-aspartate (NMDA) receptor antagonist that leads to increased synaptic plasticity and may elicit a rapid antidepressant response in individuals with depression.In Canada, a number of formulations of ketamine are approved for general anesthesia. However, antidepressant effects of ketamine have been observed in animal models of depression and in human studies of depression, and ketamine has showed potential as a novel, rapid-acting therapeutic option for patients with TRD and PTSD., The purpose of this report is to update the previous 2017 CADTH report and to examine the clinical effectiveness, cost-effectiveness and evidence-based guidelines on the use of intravenous ketamine for adults with TRD or PTSD.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.004
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesMeta-epidemiology (narrow)
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.644
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.004
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0070.001
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.088
GPT teacher head0.385
Teacher spread0.297 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; both teacher heads agree on what is shown here.

Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations10
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueEurope PMC (PubMed Central)Same topicTreatment of Major DepressionFrench-language works237,207